Gene transfer of pro-IL-18 and IL-1beta converting enzyme cDNA induces potent antitumor effects in L1210 cells. (Q40584420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

title

Gene transfer of pro-IL-18 and IL-1beta converting enzyme cDNA induces potent antitumor effects in L1210 cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Zhang B

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Wu KF

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Lin YM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Ma XT

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Rao Q

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Cao ZY

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Li G

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Song YH

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

language of work or name

1 reference

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

817-825

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

Gene therapy for hematological malignancies

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Antitumor and antimetastatic activity of IL-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Prospects for CD40-directed experimental therapy of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Spontaneous resistance to acute T-cell leukaemias in TCRV gamma 1.1J gamma 4C gamma 4 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Immunogene therapy against mouse leukemia using B7 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Immunomodulation of cancer: potential use of selectively replicating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Interferon-gamma-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Antitumor activity of interleukin-18 against the murine T-cell leukemia/lymphoma EL-4 in syngeneic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

7 January 2021

Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

7 January 2021

Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

7 January 2021

Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

7 January 2021

Clinical significance of IL-18 gene over-expression in AML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

7 January 2021

Interleukin-18 in combination with IL-2 enhances natural killer cell activity without inducing large amounts of IFN-gamma in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

7 January 2021

Expression of IL-18 and its receptor in human leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

7 January 2021

Interleukin-18 acts as an angiogenesis and tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403320

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

24 November 2019

1032589065

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14990975%20AND%20SRC:MED&resulttype=core&format=json